Register for our free email digests:
Latest From SI-Bone Inc.
A top FDA device official says the agency is hoping to finalize an additive manufacturing guidance this year. Industry is particularly interested in seeing the leap-frog guidance made final, but would also like to see more clarification and a separate guidance to address the topic of patient-specific manufacturing.
Device companies are not stepping up as much as they should be to make their raw trial data available for analysis by independent researchers, cardiologists said at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
Epigenomics, RainDance, and Brightree name new leadership, and more personnel news from around the industry.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- Musculoskeletal & Connective Tissue Disorders
- North America
- Parent & Subsidiaries
- SI-Bone Inc.
- Senior Management
Jeffrey Dunn, Pres. & CEO
Laura Francis, CFO
Joe Powers, VP, Mktg.
Mark A Reiley, MD, CMO
Tony Recupero, Chief Commercial Officer
- Contact Info
Phone: (408) 207-0700
3055 Olin Ave., Ste. 2200
San Jose, CA 95128
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.